Related Experiment Videos
Percutaneous balloon mitral valvuloplasty: the learning curve
C S Rihal1, R A Nishimura, D R Holmes
1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
American Heart Journal
|December 11, 1991
Summary
Percutaneous balloon mitral valvuloplasty (PBMV) effectively relieves mitral stenosis symptoms and improves valve function. Patient selection and operator experience are key to successful outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Mitral stenosis obstructs blood flow, causing symptoms.
- Percutaneous balloon mitral valvuloplasty (PBMV) offers a non-surgical treatment option.
Purpose of the Study:
- To evaluate the efficacy and safety of PBMV for symptomatic mitral stenosis.
- To identify factors influencing procedural outcomes.
Main Methods:
- Retrospective analysis of 50 patients undergoing PBMV at Mayo Clinic since 1986.
- Utilized Inoue or dual-balloon techniques.
- Assessed hemodynamic and symptomatic results, including mitral valve area and transmitral gradient.
Main Results:
- Mean mitral valve area increased significantly (1.06 to 2.01 cm2).
- Mean transmitral gradient decreased significantly (15.7 to 7.5 mm Hg).
- Symptomatic and hemodynamic improvements were sustained.
- Procedural success rates improved due to refined patient selection, technical advances, and operator experience.
Conclusions:
- PBMV is a safe and effective treatment for select patients with mitral stenosis.
- Favorable outcomes depend on valve morphology, patient health, and operator expertise.
- Thick, calcified valves, poor medical status, and inexperience are associated with unfavorable results.